4 completed. 2 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow PrecisionBiotics Group Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of Bifidobacterium Longum 1714® in a Population With Low Mood Bifidobacterium longum 1714® strain, Placebo - Low Mood, Depressive Symptoms | Not applicable | Completed | PrecisionBiotics Group Ltd. | 168 | 2021-09-13 | 2022-11-10 |
| Effect of 35624® Alflorex® in Functional Gastrointestinal Disorders (FGIDs) in Children. Alflorex® - Functional Gastrointestinal Disorders, Functional Abdominal Pain | Not applicable | Completed | PrecisionBiotics Group Ltd. | 65 | 2021-08-06 | 2023-09-08 |
| Effect of B. Longum 1714™ on Sleep Quality Probiotic capsule, Placebo capsule - Subjective Sleep Quality, Objective Sleep Quality | Phase 2 | Completed | PrecisionBiotics Group Ltd. | 89 | 2020-01-06 | 2020-06-30 |
| The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome Probiotic capsule - IBS - Irritable Bowel Syndrome, Depression, Anxiety | Phase 1 / Phase 2 | Completed | PrecisionBiotics Group Ltd. | 40 | 2017-09-20 | 2020-06-09 |
Depression (2) · Sleep Initiation and Maintenance Disorders (2) · Anxiety Disorders (1) · Consciousness Disorders (1) · Gastrointestinal Diseases (1) · Irritable Bowel Syndrome (1)
Probiotics (2)
Ireland (3) · Chile (1)
Eileen Murphy, PhD (3) · Ted Dinan (1)